OraQuick Advance test marketing
This article was originally published in The Tan Sheet
Executive Summary
A consumer counseling system with 24-hour phone and online assistance will be developed for use with the OraQuick Advance Rapid HIV-1/2 Antibody Test in the OTC market, according to an agreement OraQuick marketer OraSure and health services provider Constella Group announce April 12. In addition to helping customers use OraQuick, the system will provide medical referrals when needed, according to a release. It also will be a "critical component" of product development as OraSure prepares to apply to FDA for OTC approval of OraQuick, the company said. OraSure, which expects to continue conducting clinical work on the product into 2008, received support for nonprescription marketing of the product from an FDA advisory committee in 2005 (1"The Tan Sheet" Nov. 7, 2005, p. 7)...
You may also be interested in...
Advisory Panel Shows Support for OTC HIV Test, Highlights Community Need
Over-the-counter availability of a rapid HIV test would provide a public health benefit, members of FDA's Blood Products Advisory Committee generally agreed at a Nov. 3 meeting in Gaithersburg, Md
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.